We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.2B
AUM Growth
-$335M
(-1.3%)
Cap. Flow
-$2.05B
Cap. Flow
% of AUM
-8.13%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
1,147
New
127
Increased
298
Reduced
504
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 2 |
Masco
MAS
|
+$134M |
| 3 |
Lam Research
LRCX
|
+$112M |
| 4 |
Coupang
CPNG
|
+$101M |
| 5 |
Nu Holdings
NU
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$205M |
| 2 |
Lennox International
LII
|
+$191M |
| 3 |
NVIDIA
NVDA
|
+$169M |
| 4 |
Tractor Supply
TSCO
|
+$157M |
| 5 |
Apple
AAPL
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.69% |
| 2 | Consumer Discretionary | 12.85% |
| 3 | Industrials | 12.71% |
| 4 | Financials | 12.68% |
| 5 | Healthcare | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALMS
926
Alumis Inc
ALMS
$3.45B
| $160K | ﹤0.01% |
+40,162
| New | +$165K |
|
927
CSP Inc
CSPI
$81.9M
| $154K | ﹤0.01% |
13,314
-6,692
| -33% | -$78.4K |
|
928
Mitek Systems
MITK
$758M
| $152K | ﹤0.01% |
15,578
| – | – |
|
929
Kaltura
KLTR
$217M
| $151K | ﹤0.01% |
104,887
| – | – |
|
930
Crawford & Co Class A
CRD.A
$551M
| $150K | ﹤0.01% |
14,019
-42,375
| -75% | -$446K |
|
|
IMA
931
ImageneBio Inc
IMA
$65.5M
| $144K | ﹤0.01% |
17,708
+1,199
| +7% | +$15.9K |
|
932
Vaalco Energy
EGY
$540M
| $135K | ﹤0.01% |
+33,611
| New | +$130K |
|
933
Pyxis Oncology
PYXS
$184M
| $134K | ﹤0.01% |
+60,333
| New | +$86.9K |
|
934
Accel Entertainment
ACEL
$1.01B
| $131K | ﹤0.01% |
11,842
+764
| +7% | +$8.93K |
|
|
INN
935
Summit Hotel Properties
INN
$743M
| $126K | ﹤0.01% |
22,955
-733,276
| -97% | -$4M |
|
936
Orion
OEC
$400M
| $124K | ﹤0.01% |
16,301
-10,317
| -39% | -$104K |
|
937
American Outdoor Brands
AOUT
$159M
| $114K | ﹤0.01% |
13,131
-7,491
| -36% | -$71K |
|
938
KVH Industries
KVHI
$172M
| $113K | ﹤0.01% |
+20,263
| New | +$112K |
|
939
Veru
VERU
$35.8M
| $110K | ﹤0.01% |
+28,907
| New | +$125K |
|
940
1stdibs.com
DIBS
$146M
| $104K | ﹤0.01% |
40,328
+7,132
| +21% | +$19.4K |
|
941
PMV Pharmaceuticals
PMVP
$58.7M
| $96.1K | ﹤0.01% |
+68,668
| New | +$95K |
|
942
Comtech Telecommunications
CMTL
$51.5M
| $92.4K | ﹤0.01% |
+35,795
| New | +$81.8K |
|
943
Alta Equipment Group
ALTG
$207M
| $83.3K | ﹤0.01% |
+11,500
| New | +$89.4K |
|
944
Metagenomi Therapeutics
MGX
$45.6M
| $81K | ﹤0.01% |
34,169
| – | – |
|
945
Oportun Financial
OPRT
$264M
| $79K | ﹤0.01% |
12,810
| – | – |
|
946
BARK
BARK
$78.4M
| $76.8K | ﹤0.01% |
4,623
-25,619
| -85% | -$453K |
|
947
Annexon
ANNX
$814M
| $68.9K | ﹤0.01% |
+22,589
| New | +$56.1K |
|
|
VTYX
948
DELISTED
Ventyx Biosciences
VTYX
| $60.9K | ﹤0.01% |
+19,577
| New | +$51.9K |
|
949
Future Fuel
FF
$202M
| $50.8K | ﹤0.01% |
+13,105
| New | +$51.7K |
|
950
DHI Group
DHX
$178M
| $48.5K | ﹤0.01% |
+17,464
| New | +$48.3K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2025 Portfolio in Review
As of Q3 2025, Jacobs Levy Equity Management held 1,147 positions worth $25.2B, down 1.3% from $25.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jacobs Levy Equity Management withdrew a net $2.05B in Q3 2025, closing 194 positions and reducing 504 holdings. Its most notable exit was Progressive, an estimated $66.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bank of America worth $45M.
- Jacobs Levy Equity Management's largest Q3 2025 buy was Bank of America: 873,228 shares worth $45M.
- Jacobs Levy Equity Management added most to Alnylam Pharmaceuticals in Q3 2025, an estimated $160M increase.
- Jacobs Levy Equity Management's biggest Q3 2025 reduction was GE Vernova, cutting an estimated $205M.
- Jacobs Levy Equity Management fully exited Progressive in Q3 2025, selling an estimated $66.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 27% of its $25.2B portfolio in Q3 2025.
- Jacobs Levy Equity Management opened 127 new positions and closed 194 in Q3 2025.
- Jacobs Levy Equity Management's portfolio value fell 1.3% quarter-over-quarter to $25.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.